Mark Worthington - 03 Nov 2021 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
General Counsel
Signature
/s/ Glenna Mileson, Attorney in Fact for Mark Worthington
Issuer symbol
ATHA
Transactions as of
03 Nov 2021
Net transactions value
$0
Form type
4
Filing time
05 Nov 2021, 17:03:34 UTC
Previous filing
01 Jun 2021
Next filing
20 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 03 Nov 2021 Common Stock 150,000 $15.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vest on June 1, 2022 and one-fourth of the shares subject to the option vest on each subsequent anniversary thereafter.